Drowsiness News and Research

RSS

Common medications can masquerade as dementia in seniors

By all accounts the woman, in her late 60s, appeared to have severe dementia. She was largely incoherent. Her short-term memory was terrible. She couldn't focus on questions that medical professionals asked her.

18 Jul 2019

Herbal supplement used to treat addiction and pain is not safe, research says

The herb kratom is increasingly being used to manage pain and treat opioid addiction, but it's not safe to use as an herbal supplement, according to new research led by faculty at Binghamton University, State University of New York.

9 Jul 2019

Is it a feminist right to want more sex? One company thinks a pill is the answer

Studies have never defined a "normal" level of sexual desire. Despite that, there's a website and an online quiz to help you decide if you've got a problem. Called "Right to Desire," it brands libido as a feminist "right," and its home page offers the defiant, in-your-face prompt: "Yes, I want my desire back."

11 May 2019

Appendix removal linked to increased risk of Parkinson's disease

People who have had their appendix removed may be at an increased risk for developing Parkinson’s disease, according to new research.

10 May 2019

New research to investigate impact of therapy animals on pediatric cancer patients

The sight of a dog in a therapy vest trotting down a hospital hallway or being petted by a child lying in a hospital bed is familiar to many, yet the scientific research showing the impact of therapy animals is largely anecdotal, says Vanderbilt University School of Nursing Professor Mary Jo Gilmer, PhD, FAAN. Her work is changing that.

27 Apr 2019

FDA authorizes marketing of first medical device to treat ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.

22 Apr 2019

Older adults with type 1 diabetes have hypoglycemia over an hour a day

Older adults with type 1 diabetes typically have low blood sugar, or hypoglycemia, for more than an hour a day, suggests research to be presented Monday, March 25 at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.

25 Mar 2019

New AI can identify, predict development of different combinations of cancer symptoms

Cancer patients who undergo chemotherapy could soon benefit from a new AI that is able to identify and predict the development of different combinations of symptoms - helping to alleviate much of the distress caused by their occurrence and severity.

20 Feb 2019

New class of sleeping pill preserves ability to wake in response to danger signals

In a trial of one of the main class of prescription sleeping pills, half the participants slept through a fire alarm as loud as someone vacuuming next to their bed. But a newer alternative preserves the ability to wake in response to danger signals, according to a new research.

11 Jan 2019

Cancer patients who take beta-blocker along with breast cancer drug have less heart damage

Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented today at EuroEcho-Imaging 2018.

5 Dec 2018

$People with Alzheimer’s disease using strong opioids have increased risk of hip fracture$

People with Alzheimer’s disease using strong opioids have increased risk of hip fracture

People using strong painkillers, opioids, have twice the risk of hip fracture compared to non-opioid users, a new study from the University of Eastern Finland shows. The risk was highest in the first two months of opioid use.

26 Nov 2018

Wellspring celebrates grand opening of its compounding pharmacy division

Wellspring celebrated its compounding pharmacy division's grand opening with a ribbon cutting attended by over 60 guests, including Berkeley Mayor Jesse Arreguín, on Tuesday, October 30th at its new location.

2 Nov 2018

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.

23 Oct 2018

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

Regular use of party drug GHB associated with brain changes

Scientists have discovered that regular use of the party drug GHB, and especially unconsciousness following GHB use, is associated with brain changes including negative effects on long-term memory, working memory, IQ, and higher levels of stress and anxiety.

8 Oct 2018

People who have slept lesser than seven hours have higher risks of car crashes

A new study in SLEEP indicates that people who have slept for fewer than seven of the past 24 hours have higher odds of being involved in and responsible for car crashes. The risk is greatest for drivers who have slept fewer than four hours.

18 Sep 2018

Vomiting - why so common in kids?

Most kids vomit easily and often copiously and frequently. This is a global phenomenon most parents have resigned themselves to. Researchers have now tried to understand why kids vomit so commonly and if there is actually any reason for parents to panic. An article by Erin Blakemore for NPR looks to answer the question.

11 Sep 2018

Researchers develop new generation of pain medications

Researchers from Charité - Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.

7 Sep 2018

UQ drug expert supports current medicinal cannabis policies in Australia

Cannabis-based medicines should only be used under medical supervision until clinical studies have assessed their safety and efficacy, a University of Queensland drug expert has cautioned.

5 Sep 2018

Eagle Pharmaceuticals completes enrollment of second clinical study to evaluate safety, efficacy of RYANODEX

Eagle Pharmaceuticals, Inc. today announced completion of enrollment of the Company's second clinical study to further evaluate the safety and efficacy of RYANODEX® (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke, an investigational new indication for the product.

30 Aug 2018